HOLLOW ARRAY SOLID MEMBRANE FOR BLOOD OXYGENATORS

Information

  • Research Project
  • 6184059
  • ApplicationId
    6184059
  • Core Project Number
    R44HL057742
  • Full Project Number
    5R44HL057742-04
  • Serial Number
    57742
  • FOA Number
  • Sub Project Id
  • Project Start Date
    6/20/1997 - 27 years ago
  • Project End Date
    8/31/2002 - 22 years ago
  • Program Officer Name
  • Budget Start Date
    9/1/2000 - 24 years ago
  • Budget End Date
    8/31/2002 - 22 years ago
  • Fiscal Year
    2000
  • Support Year
    4
  • Suffix
  • Award Notice Date
    9/15/2000 - 24 years ago
Organizations

HOLLOW ARRAY SOLID MEMBRANE FOR BLOOD OXYGENATORS

Microporous membrane hollow fibers (MMHF) have become standard in blood oxygenating devices used for short term cardiorespiratory support procedures. These devices used for short term cardiorespiratory support procedures. These devices have become popular mainly because of enhanced gas exchange due to the convective mixing induced by the blood flowing on the outside of thousands of tiny hollow fibers. This property allows for designing highly efficient gas exchange devices in relatively compact volumes. Yet MMHF suffer from plasma leakage when they are used for extended periods of time, and from gas embolization when the gas side pressure exceed the blood side pressure, exceed the blood side pressure. Thus the compactness and effectiveness of the MMHF, plus the ability of solid silicone membranes to withstanding plasma leakage and gas embolization are desirable properties in a membrane designed blood oxygenation. We have devised a technique that will allow for the fabrication of a solid silicone membrane configured in a uniform hollow three-dimensional array, such that gas can flow in the inside and blood on the outside of this hollow array. This design allows for uniform convective mixing, and unlimited flexibility in design parameters. In Phase II we proposed to further develop the fabrication technique and to evaluate the membrane design parameters for gas exchange and hemodynamic performance. PROPOSED COMMERCIAL APPLICATIONS: The proposed membrane will significantly enhance safety and performance of blood oxygenators used for cardiopulmonary bypass operations. There are over 300,000 disposable oxygenators used in the US every year.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R44
  • Administering IC
    HL
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    322563
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:322563\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    MEDARRAY, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    ANN ARBOR
  • Organization State
    MI
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    48103
  • Organization District
    UNITED STATES